Totvs (TOTS3) Plunges 10% in Second Straight Day of Losses on B3: What’s Behind the Sell-Off?
- Why Is Totvs (TOTS3) Crashing?
- Financial Impact: Debt Relief and Valuation
- Analyst Ratings: Buy or Hold?
- What’s Next for Totvs?
- Q&A: Key Investor Concerns
Totvs (TOTS3) shares are leading the losers on Brazil’s Ibovespa (IBOV) for the second consecutive day, plummeting 10% amid a market reaction to the sale of its joint venture Dimensa. The stock hit an intraday low of R$39.24, marking the steepest decline among Ibovespa components. With over 27,200 trades and a financial turnover of R$295.8 million, Totvs is also the second most-traded stock on B3. Analysts weigh in on whether this is a buying opportunity or a sign to stay away.
Why Is Totvs (TOTS3) Crashing?
The sharp decline follows the announcement that Totvs and B3 (B3SA3) sold their joint venture Dimensa to Evertec, a Latin American fintech multinational, for R$950 million. The deal, disclosed on February 2, is still pending regulatory approvals, including clearance from Brazil’s antitrust watchdog CADE. Investors were caught off guard—while rumors of a sale had circulated since mid-2025, few expected it to materialize this soon.
Despite the sell-off, analysts see strategic merit in the move. Itau BBA notes that Dimensa was "not a long-term strategic asset" for Totvs, and the sale improves capital allocation flexibility. Bank of America adds that the transaction reduces revenue volatility, as Dimensa’s contract renewal structure differed from Totvs’ Core operations.
Financial Impact: Debt Relief and Valuation
The sale cuts Totvs’ net leverage to ~0.9x (net debt/EBITDA), down from Itau BBA’s estimated 1.2x for 2026. Safra calculates the deal unlocks R$1.4 billion in equity value, with an enterprise value of R$950 million. However, Citi warns that Totvs’ current pricing is "fair," offering limited upside compared to peers.
Analyst Ratings: Buy or Hold?
Most analysts maintain bullish ratings, though price targets vary widely:
| Bank/Broker | Recommendation | Price Target | Upside Potential* |
|---|---|---|---|
| Bank of America (BofA) | Buy | R$62.00 | 42.20% |
| BTG Pactual | Buy | R$55.00 | 26.15% |
| Itau BBA | Buy | R$60.00 | 37.61% |
| Safra | Neutral | R$47.00 | 7.80% |
| Santander | Buy | R$61.00 | 39.91% |
*Based on February 3 closing price of R$43.60. Source: TradingView
What’s Next for Totvs?
The company now shifts focus to cloud services and AI integration—key growth drivers post-Linx acquisition. While short-term pain persists, the BTCC team notes that "divesting non-core assets often pays off in 12-18 months." Still, with shares down 11.4% over three sessions and year-to-date losses at 6.2%, investors remain wary.
This article does not constitute investment advice. Market data via TradingView.
Q&A: Key Investor Concerns
Why did Totvs sell Dimensa?
The joint venture wasn’t central to Totvs’ long-term cloud and AI strategy. The sale allows management to focus on higher-growth areas.
Is the current drop an overreaction?
Possibly. While the timing surprised markets, analysts largely view the deal as strategically sound. The 10% plunge may reflect short-term sentiment rather than fundamentals.
What’s the biggest risk now?
Execution. Totvs must prove it can reinvest the proceeds effectively into its CORE businesses amid tough macroeconomic conditions.
